sj-xlsx-1-tam-10.1177_17588359221100863 – Supplemental material for Durable benefit and change in TCR clonality with nivolumab in a Lynch syndrome–associated glioma
收藏DataCite Commons2024-08-28 更新2025-04-16 收录
下载链接：
https://sage.figshare.com/articles/dataset/sj-xlsx-1-tam-10_1177_17588359221100863_Supplemental_material_for_Durable_benefit_and_change_in_TCR_clonality_with_nivolumab_in_a_Lynch_syndrome_associated_glioma/20045208/1
下载链接
链接失效反馈官方服务：
资源简介：
Supplemental material, sj-xlsx-1-tam-10.1177_17588359221100863 for Durable benefit and change in TCR clonality with nivolumab in a Lynch syndrome–associated glioma by Santiago Cabezas-Camarero, Rebeca Pérez-Alfayate, Vanesa García-Barberán, María Carmen Polidura, María Natividad Gómez-Ruiz, Isabel Casado-Fariñas, Issa Ahmad Subhi-Issa, José Carlos Plaza Hernández, Pilar Garre, Isabel Díaz-Millán and Pedro Pérez-Segura in Therapeutic Advances in Medical Oncology
补充材料sj-xlsx-1-tam-10.1177_17588359221100863，对应Santiago Cabezas-Camarero、Rebeca Pérez-Alfayate、Vanesa García-Barberán、María Carmen Polidura、María Natividad Gómez-Ruiz、Isabel Casado-Fariñas、Issa Ahmad Subhi-Issa、José Carlos Plaza Hernández、Pilar Garre、Isabel Díaz-Millán及Pedro Pérez-Segura发表于《医学肿瘤学治疗进展》（*Therapeutic Advances in Medical Oncology*）的论文《纳武利尤单抗在林奇综合征相关胶质瘤中的持久获益与T细胞受体克隆性（TCR clonality）变化》
提供机构：
SAGE Journals
创建时间：
2022-06-10
